eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Laryngology
Recurrent Respiratory Papillomatosis
Updated: Oct 29, 2008
Introduction
Recurrent respiratory papillomatosis (RRP) is a benign lesion of the larynx and trachea. Recurrent respiratory papillomatosis (RRP) is caused by the human papillomavirus (HPV), which similarly causes warts often visible on the skin, especially on the hands.
Recurrent respiratory papillomatosis (RRP) is most commonly observed in children, but it can occur in adults. Although lesions histologically and pathologically seem similar in children and adults, clinically they behave much differently. Children often require multiple surgical procedures, and their disease often becomes quiescent in adolescence. Adults with recurrent respiratory papillomatosis (RRP) usually require only a few surgical excisions for cure. Recurrent respiratory papillomatosis (RRP) can be a devastating disease for a child, occasionally necessitating up to 150 surgeries over the child's lifetime. Recurrent respiratory papillomatosis (RRP) is one of the most common causes of hoarseness and airway obstruction in children.
History of the Procedure
Historically, recurrent respiratory papillomatosis (RRP) was believed to be a surgical disease only. However, because of its significant recurrence rate, various medications have been attempted over the last 2 decades with varying degrees of success. In 1990, human papillomavirus (HPV) was discovered as the etiologic agent responsible for papilloma in the larynx and trachea. Since this discovery, the disease mechanism has been extensively investigated, and new antivirals have been tested. International meetings devoted solely to HPV have been organized.
In 1995, the Centers for Disease Control and Prevention (CDC) created a recurrent respiratory papillomatosis (RRP) task force to learn more about the disease. Because recurrent respiratory papillomatosis (RRP) in children is rare and its clinical course hard to predict, the task force combined data from 20 institutions and children's hospitals around the country. The initial goal of the recurrent respiratory papillomatosis (RRP) task force was to diagnose the true incidence and prevalence of the disease because most medical centers have only 15-40 patients with recurrent respiratory papillomatosis (RRP), even in large metropolitan areas.
Once the epidemiology of the disease is established, then prospective medical and surgical therapy trials can be evaluated more thoroughly in large groups of patients. Today, despite these efforts, human papillomavirus (HPV) is still misdiagnosed as asthma, croup, or chronic bronchitis because they all display symptoms of airway obstruction. However, as the disease becomes better known, recurrent respiratory papillomatosis (RRP) diagnosis will be made more often.
Problem
Recurrent respiratory papillomatosis (RRP) is a wart on the laryngeal, tracheal, bronchial, or other respiratory mucosa.
Frequency
Based on a survey of otolaryngologists, 1500-2500 new cases of childhood-onset recurrent respiratory papillomatosis (RRP) are estimated to occur each year in the United States. Incidence among children in the United States is estimated at 4.3 cases per 100,000 persons. Adult incidence is estimated at 1.8 cases per 100,000 persons.
The distribution of cases of recurrent respiratory papillomatosis (RRP) is bimodal, with an initial peak in the childhood years and a second peak in the adult years in people aged 20-40 years.
In children, the male-to-female ratio is approximately equal. For adults, the male-to-female ratio may be 4:1. Childhood onset for recurrent respiratory papillomatosis (RRP) is more common and more aggressive than in adults. Most children with recurrent respiratory papillomatosis (RRP) appear to be the first born of young mothers and come from families with low economic status.
Roughly 15,000 surgical procedures are performed each year at an estimated cost of $100 million.
Etiology
Human papillomavirus (HPV) causes recurrent respiratory papillomatosis (RRP). Seventy types of human papillomaviruses (HPVs) have been identified. Human papillomavirus (HPV) types 6 and 11 cause benign papilloma in the airway and are responsible for genital warts. Human papillomavirus (HPV) types 16 and 18 have most often been associated with cancer in the genital area and upper aerodigestive tract in both children and adults.
In patients with laryngeal papilloma, normal mucosa has human papillomavirus (HPV) in 20% of cases. In otherwise normal airways, human papillomavirus (HPV) deoxyribonucleic acid (DNA) has been retrieved from laryngeal and tracheal mucosa in 4% of cases.
Pathophysiology
Childhood-Onset Recurrent Respiratory Papillomatosis
The precise mode of human papillomavirus (HPV) transmission is unclear. Most studies indicate that childhood-onset recurrent respiratory papillomatosis (CORRP) occurs during exposure of a child's upper aerodigestive tract to the cervix and vagina of a mother with genital human papillomavirus (HPV) infection during normal abdominal delivery. Why CORRP develops in only a few percent of children who are born abdominally to mothers with active genital condyloma is not well understood.
Statistics
- In 1998, Shah et al reported the risk of an abdominally delivered child contracting RRP from a mother who has active condylomatous lesions at approximately 1 in 400.1
- Fifty percent of mothers of affected children had active or previous condylomata.
- Human papillomavirus (HPV) was recovered on nasopharyngeal swab from a third of infants born to mothers with active uterine human papillomavirus (HPV).
- In the United States, 1 million cases of genital papilloma per year manifested as condyloma acuminatum involving the cervix, vulva, penis, or other anogenital sites.
- Clinically apparent human papillomavirus (HPV) infection has been noted in 1.5-5% of pregnant women in the United States. Human papillomavirus (HPV) has been recovered in up to 20% of disease-free mucosa in the anogenital area of pregnant women.
Factors possibly contributing to development of HPV
- Status of the child's immune system
- Length of time in the birth canal
- Volume of virus in the birth canal
- Abdominal delivery: One case reports a child born by cesarean delivery (with no premature ruptured membrane) who developed recurrent respiratory papillomatosis (RRP), casting doubt on the birth canal theory.
- Presence of local trauma
Adult-Onset Recurrent Respiratory Papillomatosis
For adult-onset recurrent respiratory papillomatosis (AORRP), oroanal or orogenital contact is considered a possible mode of virus transmission versus a latent virus becoming active. Ten percent of sexually active men and women with no clinical evidence of disease have human papillomavirus (HPV) identified in the penis or cervix by Southern blot hybridization analysis, suggesting presence of latent infection.
Virus mechanisms
- Once transmitted to the airway, human papillomavirus (HPV) establishes itself in the basal layer of the mucosa, where viral DNA enters the cell and produces ribonucleic acid (RNA) to produce viral proteins, similar to the replication mechanism of other viruses. This action incites the transformation of the mucosa to papilloma formation.
- In 1993, Kashima et al reported an increased risk of papilloma in the airway at sites of squamous epithelium or squamous metaplasia.2
Presentation
Childhood-Onset Recurrent Respiratory Papillomatosis
Children with CORRP usually present when aged 2-3 years with hoarseness, stridor, or airway obstruction. Papilloma has been reported to manifest as early as the first day of life or as late as the octogenarian years.
Symptoms and signs
- Stridor usually begins as an inspiratory noise consistent with glottic or supraglottic disease but then becomes biphasic with progression of disease.
- As the papilloma grows, the airway obstructive features worsen. Other clinical presentations include cough, pneumonias, and dysphagia. Children are often misdiagnosed with asthma, croup, allergies, vocal nodules, or bronchitis. Recurrent respiratory papillomatosis (RRP) is misdiagnosed because of its rarity and the slowly progressive nature of the disease. Hoarseness without airway obstruction may indicate the small lesion.
- Aphonia or breathy voice suggests a larger glottic lesion.
- A low-pitched, coarse, fluttering voice suggests a subglottic lesion.
- Children with papillomas of the larynx do not usually become symptomatic before age 6 months.
- Document the quality of the voice on physical examination.
- Signs of severe airway obstruction include tachypnea, stridor, retractions (suprasternal, substernal, intracostal), flaring of the nasal ala, and use of accessory neck or chest muscles.
- Increasing air hunger may cause the child to sit with the neck hyperextended in an attempt to improve airflow.
- All children with any of the signs of stable airway obstruction or voice disturbances must have a flexible fiberoptic nasopharyngoscopy in clinic.
Indications
Indications for surgery in recurrent respiratory papillomatosis (RRP) are based on the presence or absence of a lesion that causes symptoms. Laryngeal lesions, if present, usually cause symptoms and must be removed or treated. In a patient undergoing multiple surgeries a year, a lesion may only need to be removed because it is symptomatic and not necessarily every lesion needs to be removed in every surgical procedure. Surgical excision is the current standard of care in the treatment of recurrent respiratory papillomatosis (RRP). Adjuvant medical therapy has been investigated over the past 2 decades and continues to this day.
If the child or adult has only hoarseness, surgery can be scheduled as an elective procedure. If the child or adult has airway obstruction, immediately treat it as an emergency procedure.
Relevant Anatomy
During surgical removal, use caution to spare all vital structures and to prevent iatrogenic scarring of the larynx or trachea.
Up to 30% of patients who have had surgical excision of papilloma in the anterior commissure of the larynx have developed anterior glottic scarring and web formation. Unless the surgeon can be assured that iatrogenic injury will not result from their technique, papilloma should be left in the anterior commissure in children requiring several surgeries a year.
A small percentage of patients have developed subglottic stenosis from repeated surgical excisions at the anterior commissure of the larynx.
Avoid tracheotomy at almost all cost. Frequent surgical excision (ie, as often as once per 2 wk) is preferable to tracheotomy for children or adults who have recurrent aggressive disease. Tracheotomy is believed to induce spread of the papilloma down the trachea and into the bronchi and lungs.
Contraindications
No contraindications to surgical removal of recurrent respiratory papillomatosis (RRP) exist.
More on Recurrent Respiratory Papillomatosis |
Overview: Recurrent Respiratory Papillomatosis |
| Workup: Recurrent Respiratory Papillomatosis |
| Treatment: Recurrent Respiratory Papillomatosis |
| Follow-up: Recurrent Respiratory Papillomatosis |
| References |
| Next Page » |
References
Shah KV, Stern WF, Shah FK, et al. Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr Infect Dis J. May 1998;17(5):372-6. [Medline].
Kashima H, Mounts P, Leventhal B, Hruban RH. Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. Aug 1993;102(8 Pt 1):580-3. [Medline].
Kashima HK, Mounts P, Shah K. Recurrent respiratory papillomatosis. Obstet Gynecol Clin North Am. Sep 1996;23(3):699-706. [Medline].
Abramson AL, Shikowitz MJ, Mullooly VM, et al. Variable light-dose effect on photodynamic therapy for laryngeal papillomas. Arch Otolaryngol Head Neck Surg. Aug 1994;120(8):852-5. [Medline].
Pou AM, Rimell FL, Jordan JA, et al. Adult respiratory papillomatosis: human papillomavirus type and viral coinfections as predictors of prognosis. Ann Otol Rhinol Laryngol. Oct 1995;104(10 Pt 1):758-62. [Medline].
Pransky SM, Magit AE, Kearns DB, et al. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg. Oct 1999;125(10):1143-8. [Medline].
Derkay CS, Malis DJ, Zalzal G, et al. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope. Jun 1998;108(6):935-7. [Medline].
Buchinsky FJ, Donfack J, Derkay CS, et al. Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS ONE. May 28 2008;3(5):e2263. [Medline].
Armstrong LR, Derkay CS, Reeves WC. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg. Jul 1999;125(7):743-8. [Medline].
Avidano MA, Singleton GT. Adjuvant drug strategies in the treatment of recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg. Feb 1995;112(2):197-202. [Medline].
Bishai D, Kashima H, Shah K. The cost of juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. Aug 2000;126(8):935-9. [Medline].
Bonnez W, Kashima HK, Leventhal B, et al. Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP). Virology. May 1992;188(1):384-7. [Medline].
Cole RR, Myer CM 3rd, Cotton RT. Tracheotomy in children with recurrent respiratory papillomatosis. Head Neck. May-Jun 1989;11(3):226-30. [Medline].
Crockett DM, McCabe BF, Shive CJ. Complications of laser surgery for recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. Nov-Dec 1987;96(6):639-44. [Medline].
Doyle DJ, Gianoli GJ, Espinola T, et al. Recurrent respiratory papillomatosis: juvenile versus adult forms. Laryngoscope. May 1994;104(5 Pt 1):523-7. [Medline].
Doyle DJ, Henderson LA, LeJeune FE Jr, et al. Changes in human papillomavirus typing of recurrent respiratory papillomatosis progressing to malignant neoplasm. Arch Otolaryngol Head Neck Surg. Nov 1994;120(11):1273-6. [Medline].
Eicher SA, Taylor-Cooley LD, Donovan DT. Isotretinoin therapy for recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. Apr 1994;120(4):405-9. [Medline].
Endres DR, Bauman NM, Burke D, et al. Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study. Ann Otol Rhinol Laryngol. Apr 1994;103(4 Pt 1):301-5. [Medline].
Fisher R, Darrow DH, Tranter M, et al. Human papillomavirus vaccine: recommendations, issues and controversies. Curr Opin Pediatr. Aug 2008;20(4):441-5. [Medline].
Green GE, Bauman NM, Smith RJ. Pathogenesis and treatment of juvenile onset recurrent respiratory papillomatosis. Otolaryngol Clin North Am. Feb 2000;33(1):187-207. [Medline].
Healy GB, Gelber RD, Trowbridge AL, et al. Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial. N Engl J Med. Aug 18 1988;319(7):401-7. [Medline].
Kashima HK, Shah F, Lyles A, et al. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis. Laryngoscope. Jan 1992;102(1):9-13. [Medline].
Leventhal BG, Kashima HK, Mounts P, et al. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group. N Engl J Med. Aug 29 1991;325(9):613-7. [Medline].
Lippman SM, Donovan DT, Frankenthaler RA, et al. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis. J Natl Cancer Inst. Jun 1 1994;86(11):859-61. [Medline].
Lopez Aguado D, Perez Pinero B, Betancor L,et al. Acyclovir in the treatment of laryngeal papillomatosis. Int J Pediatr Otorhinolaryngol. May 1991;21(3):269-74. [Medline].
McMurray JS, Connor N, Ford CN. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study. Ann Otol Rhinol Laryngol. Jul 2008;117(7):477-83. [Medline].
Myer CM 3rd, Willging JP, McMurray S, et al. Use of a laryngeal micro resector system. Laryngoscope. Jul 1999;109(7 Pt 1):1165-6. [Medline].
Newfield L, Goldsmith A, Bradlow HL, et al. Estrogen metabolism and human papillomavirus-induced tumors of the larynx: chemo-prophylaxis with indole-3-carbinol. Anticancer Res. Mar-Apr 1993;13(2):337-41. [Medline].
Ossoff RH, Werkhaven JA, Dere H. Soft-tissue complications of laser surgery for recurrent respiratory papillomatosis. Laryngoscope. Nov 1991;101(11):1162-6. [Medline].
Parsons DS. Rhinologic uses of powered instrumentation in children beyond sinus surgery. Otolaryngol Clin North Am. Feb 1996;29(1):105-14. [Medline].
Perkins JA, Inglis AF Jr, Richardson MA. Iatrogenic airway stenosis with recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. Mar 1998;124(3):281-7. [Medline].
Pignatari S, Smith EM, Gray SD, et al. Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. Ann Otol Rhinol Laryngol. May 1992;101(5):408-12. [Medline].
Rosen CA, Woodson GE, Thompson JW, et al. Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg. Jun 1998;118(6):810-5. [Medline].
Saleh EM. Complications of treatment of recurrent laryngeal papillomatosis with the carbon dioxide laser in children. J Laryngol Otol. Aug 1992;106(8):715-8. [Medline].
Sessions RB, Dichtel WJ, Goepfert H. Treatment of recurrent respiratory papillomatosis with interferon. Ear Nose Throat J. Oct 1984;63(10):488-93. [Medline].
Sessions RB, Goepfert H, Donovan DT, et al. Further observations on the treatment of recurrent respiratory papillomatosis with interferon: a comparison of sources. Ann Otol Rhinol Laryngol. Sep-Oct 1983;92(5 Pt 1):456-61. [Medline].
Shapiro AM, Rimell FL, Shoemaker D, et al. Tracheotomy in children with juvenile-onset recurrent respiratory papillomatosis: the Children's Hospital of Pittsburgh experience. Ann Otol Rhinol Laryngol. Jan 1996;105(1):1-5. [Medline].
Shikowitz MJ, Abramson AL, Freeman K, et al. Efficacy of DHE photodynamic therapy for respiratory papillomatosis: immediate and long-term results. Laryngoscope. Jul 1998;108(7):962-7. [Medline].
Simpson GT 2d, Strong MS. Recurrent respiratory papillomatosis: the role of the carbon dioxide laser. Otolaryngol Clin North Am. Nov 1983;16(4):887-94. [Medline].
Thurmond LM, Brand CM, Leventhal BG, et al. Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon. J Lab Clin Med. Sep 1991;118(3):232-40. [Medline].
Further Reading
Keywords
recurrent respiratory papillomatosis, RRP, laryngeal papillomas, laryngeal papillomatosis, tracheal papillomas, tracheal papillomatosis, larynx, trachea, HPV, human papillomavirus
Overview: Recurrent Respiratory Papillomatosis